Nubratori RX is an FDA Registered 503B Outsourcing Facility (OSF) and a proud member of the Outsourcing Facility Association (OFA). Nubratori RX began in 2014 as a challenge to the founder, CEO, and Pharmacist, Robert Nickell, to create the best FDA regulated national drug compounding and manufacturing facility which follows cGMP (Current Good Manufacturing Practices).

 

Nubratori RX is located in Southern California and currently exists in over 6000 square feet of non-sterile and sterile lab space, with expansion plans for doubling by the summer of 2023. Nubratori RX provides compounded sterile injectables and non-sterile topical creams, solutions, and capsules.  Nubratori RX is currently licensed to ship in 35 states plus Washington DC.

 

Under the guidance of the FDA, Outsourcing Facility products are non-patient specific, shipped across state lines, and sold to licensed Healthcare Providers for Office Use such as hospitals, physicians, and pharmacies. This allows patients to obtain clinically significant and necessary medications, ordered by their providers. Outsourcing Facility products are exempt from the new drug approval process.